Thursday 24th February 2022
Are you living with diffuse scleroderma? Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma? If so, you may be eligible to take part in the DECODE Scleroderma Study
Thursday 17th February 2022
Friday 11th February 2022
A national trial is recruiting people with scleroderma to see how they have responded to their COVID-19 vaccinations. Have they produced antibodies?
Friday 4th February 2022
STAR is the newly upgraded app for tracking your Raynaud’ symptoms. The App was created to help you manage and record your attacks, all whilst contributing to valuable scientific research in just a few simple clicks.
Monday 31st January 2022
Dorset mum says even supermarket trips can be painful: "I feel the cold a lot and struggle with things like going to the supermarket, especially visiting the cold aisles..."
Friday 21st January 2022
Welcome to 2022! The new year is a perfect opportunity to look forward and see what upcoming research is on the horizon.
Friday 14th January 2022
Are you having a good day? How we spend our time can have a significant impact on how we feel. We talked to occupational therapist Lucy Reeve about some of the small changes that could make a big difference to our wellbeing and help make every day a little bit better.
Friday 31st December 2021
As we come to the end of 2021, SRUK have been thinking about the new year, and the one after that… and the one after that. In just 12 months, we have seen huge change across the world, which got us thinking, what could things look like in 20 years?
Thursday 16th December 2021
At the 2021 SRUK Virtual Conference Dr Elizabeth Volkmann presented a very popular session on Understanding Gastrointestinal Involvement in Scleroderma – where she introduced the concept of how a person’s microbiome might influence their condition. This article takes a deeper dive into the world of the microbiome.
Friday 10th December 2021
On the 8th December the UK government announced several measures to ensure those who are most at risk from COVID-19 are given access to new treatments within their community, and where possible, within their own home.
